Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

SELL
$15.0 - $22.76 $3,105 - $4,711
-207 Reduced 50.24%
205 $3,000
Q4 2022

Feb 06, 2023

SELL
$14.16 - $24.02 $14 - $24
-1 Reduced 0.24%
412 $6,000
Q3 2022

Nov 08, 2022

BUY
$18.07 - $31.37 $18 - $31
1 Added 0.24%
413 $9,000
Q2 2022

Jul 19, 2022

BUY
$13.31 - $34.88 $5,483 - $14,370
412 New
412 $7,000
Q4 2021

Jan 24, 2022

SELL
$26.0 - $37.03 $3,796 - $5,406
-146 Closed
0 $0
Q3 2021

Oct 29, 2021

BUY
$29.75 - $37.99 $1,398 - $1,785
47 Added 47.47%
146 $5,000
Q2 2021

Aug 02, 2021

BUY
$27.5 - $38.19 $1,375 - $1,909
50 Added 102.04%
99 $4,000
Q1 2021

Apr 29, 2021

BUY
$32.52 - $61.53 $1,593 - $3,014
49 New
49 $2,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $535M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Tci Wealth Advisors, Inc. Portfolio

Follow Tci Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.